Cancer Family

Adnexal Neoplasm

Non-malignant776 active trials5 approved drugs94 evidence items

NCIt: C212119

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (171)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 171 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer.
Hugo Swenson, Ella Ittner, Lucas Werner et al. · Epigenetics · Dec 31, 2026 · PMID 42683873 · candidate dictionary pubmed
A photothermal ablation strategy for orthotopic ovarian cancer via mitochondria-dependent apoptosis.
Lei Zhou, Yongle Lv, Jinfa Huang et al. · Int J Pharm X · Dec 1, 2026 · PMID 42713249 · candidate dictionary pubmed
CellSearch-based isolation of circulating tumor cells from ascitic fluid enables molecular characterization of ovarian cancer.
Francesca Gorini, Thais Maloberti, Emma Coschina et al. · J Liq Biopsy · Dec 1, 2026 · PMID 42750947 · candidate dictionary pubmed
Brain metastases as a manifestation of late relapse in high-grade serous ovarian cancer: Diagnostic and therapeutic challenges.
Naoufal Berrada, Soufiane Bigi, Rania Mokfi et al. · Radiol Case Rep · Nov 1, 2026 · PMID 42707057 · candidate dictionary pubmed
[Corrigendum] Inactivation of von Hippel‑Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR‑210/VMP1 signaling pathway.
Ting Liu, Le Zhao, Wei Chen et al. · Int J Mol Med · Nov 1, 2026 · PMID 42725402 · candidate dictionary pubmed
KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study.
Yuanyi Wang, Juan Yu, Wu Huang et al. · Oncol Lett · Nov 1, 2026 · PMID 42750893 · candidate dictionary pubmed

[Retracted] CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.

Long-Qiao Cao, Ya-Nan Wang, Ming Liang et al. · Mol Med Rep · Nov 1, 2026 · PMID 42788365 · candidate dictionary pubmed

Selective anticancer activity of a multinuclear Cu(II) complex through apoptosis induction in ovarian cancer cells.

Li Gong, Mostafa Heidari Majd, Hamid Reza Ghaffari · Bioorg Chem · Oct 5, 2026 · PMID 42648236 · candidate dictionary pubmed

Green synthesis of silver nanoparticle using Hemidesmus indicus (L) R. Br. root extract and cytotoxicity assessment against ovarian cancer cell line (SKOV3).

Jayachandran Halka, Gayathiri Gunasangkaran, Kumaresan Kowsalya et al. · Cytotechnology · Oct 1, 2026 · PMID 42676590 · candidate dictionary pubmed

[Expression of Concern] Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells.

Jing Guo, Li Chen, Ning Luo et al. · Oncol Rep · Oct 1, 2026 · PMID 42663282 · candidate dictionary pubmed

Characterization of B cell activation and spatial distribution in the tumor microenvironment of high-grade serous ovarian cancer.

Eleonora Capezzali, Martina Arcieri, Silvia Tonon et al. · Transl Oncol · Oct 1, 2026 · PMID 42660101 · candidate dictionary pubmed

LncRNA-driven alternative splicing landscapes associate with survival outcomes in ovarian cancer.

Yan Cao, Jian Zhao, Shan He et al. · Noncoding RNA Res · Oct 1, 2026 · PMID 42633203 · candidate dictionary pubmed

Integrative single-cell sequencing and machine learning analyses identify chronic inflammation and cancer-associated fibroblast subsets as drivers of adverse outcomes in ovarian cancer.

Mingqin Kuang, Changmei Shen, Chunping Yang et al. · Transl Oncol · Oct 1, 2026 · PMID 42632123 · candidate dictionary pubmed

NCAPD2 facilitates ovarian cancer progression via MYC-mediated unfolded protein response.

Guoying Cui, Hongqi Li, Yanqiu Wang et al. · Biochim Biophys Acta Mol Cell Res · Oct 1, 2026 · PMID 42586216 · candidate dictionary pubmed

PDK1/AKT signaling is involved in the anti-tumor effect of gramine and cisplatin chemoresistance in ovarian cancer cells.

Haiyan Wang, Ruiming Zheng, Bujun Wang et al. · Exp Ther Med · Oct 1, 2026 · PMID 42719404 · candidate dictionary pubmed

Real-world outcomes after Mirvetuximab Soravtansine treatment for recurrent ovarian Cancer: Results from a university setting.

Anna V Jones, Rachel L Furuya, L Stewart Massad et al. · Gynecol Oncol Rep · Oct 1, 2026 · PMID 42733650 · candidate dictionary pubmed

Two-step PEG-based surface functionalization of gold nanoparticles enables specific SERS imaging of EGFR in an ovarian cancer cell model.

Alessandro Stumpo, Ricardo Coelho, Mónica Núñez López et al. · Mater Today Bio · Oct 1, 2026 · PMID 42741697 · candidate dictionary pubmed

Response to Sotorasib in a patient with recurrent KRAS G12C-mutated low-grade serous ovarian cancer: a case report and literature review.

Erin Hickey Zacholski, Wen Jing Liu, Ryan Clayton et al. · Gynecol Oncol Rep · Oct 1, 2026 · PMID 42756523 · candidate dictionary pubmed

Pharmacokinetic characterization of olaparib tablets in a hemodialysis patient with advanced ovarian cancer: a case report.

Teruki Yoshida, Sachiko Kitamura, Masahiro Tsuda et al. · Int Cancer Conf J · Oct 1, 2026 · PMID 42780507 · candidate dictionary pubmed

Carmofur inhibits ovarian cancer cell proliferation, migration, and invasion via disrupting the YAP-1/TEAD pathway: in vitro and in silico approaches.

Celal Cengiz, Canan Vejselova Sezer, Bahri Gür et al. · 3 Biotech · Oct 1, 2026 · PMID 42774543 · candidate dictionary pubmed

PD-1 Inhibitor (Sintilimab) Combined With Chemotherapy as Neoadjuvant Therapy in Advanced Ovarian Cancer: A Case Report.

Wang Zhenyan, Wang Yan · Clin Case Rep · Oct 1, 2026 · PMID 42801091 · candidate dictionary pubmed

Inhibition of Translesion DNA Synthesis Sensitizes BRCA-Deficient Ovarian Cancer to PARP Inhibitors.

Na Li, Kousalya Lavudi, Qianyun Ge et al. · Cancer Res · Sep 28, 2026 · PMID 42804161 · candidate dictionary pubmed

[Update on ovarian cancer].

Pauline Wimberger, Theresa Link · Pathologie (Heidelb) · Sep 28, 2026 · PMID 42803933 · candidate dictionary pubmed

Pattern of ovarian cancer recurrence and survival: final analysis of an extended cohort of 591 patients.

Edgar Petru, Katharina Eberhard, Haro Stettner et al. · Wien Med Wochenschr · Sep 28, 2026 · PMID 42803900 · candidate dictionary pubmed

Sensitizing nanomedicine for platinum-resistant ovarian cancer.

Diana Hsin-Yu Lee, William Lee, Horacio Bach · Nanomedicine (Lond) · Sep 28, 2026 · PMID 42802703 · candidate dictionary pubmed